Fundraising FoxDeerfield Management Company — 2024 Investments
9 investments dated 2024 · listed companies and verified rows first · show all
BiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security.
AI & Machine LearningBiotechCybersecurityDeep TechDefense TechHardwareNess Ziona
Jonathan Solomon(Chief Executive Officer)inMerav Bassan(Chief Development Officer)inMarina Wolfson(Chief Financial Officer)inJesse Goodman(Director)Alan Moses(Director)Jonathan Leff(Director)
Co-investorsAMR Action FundBaruch Future VenturesNSG VenturesOrbiMedSBI JI Innovation Advisory Ltd.Seventure Partners+2 more
Foghorn Therapeutics is a clinical-stage biotech developing chromatin-targeted cancer drugs via its Gene Traffic Control platform, including a candidate co-developed with Eli Lilly.
Adrian Gottschalk(President and Chief Executive Officer)
Co-investorsFlagship PioneeringXeraya CapitalBiotechnology Value Fund
MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Board seatAndrew ElBardissi· per SEC Form D
Co-investorsAndera PartnersBioStar CapitalFidelity InvestmentsRA CapitalCorewell Health VenturesFountain Healthcare Partners
Clinical-stage biotech developing next-generation polyene antifungals for life-threatening invasive fungal infections.
BiotechNew York, US
Kieren Marr(Executive Officer, Director)
BoardJim Flynn(Director)Martin Heidecker(Director)in
Board seatJonathan Leff· per SEC Form D
Co-investorsAMR Action FundIllinois Ventures
Cohere Health provides a platform aimed at aligning the interests of patients, physicians, and health plans to support care decisions and improve member outcomes.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSBoston, US
Siva Namasivayam(Executive Officer, Director)inRobert Shepardson(Executive Officer)inKristen Carucci(Executive Officer)inDuncan Reese(Executive Officer)
BoardDavid Barrett(Director)Amir Debourou(Director)
Co-investorsCota CapitalFlare Capital PartnersLongitude CapitalDefine VenturesPolaris PartnersTemasek
ElevenLabs is an AI research and product company that builds voice generation and audio processing platforms for creating human-like voice interactions with technology.
AI & Machine LearningCreator EconomyEnterprise SoftwareSaaSLondon, GB
Mati Staniszewski(Founder)inPiotr Dabkowski(Co-founder)inHannah C(Founder)Mateusz Jakub Staniszewski(Co-founder)inMati Staniszewski Piotr Dabkowski(Founder)Piotr Dąbkowski(Founder)
Co-investorsA.Capital VenturesAir Street CapitalAlkeon InnovationAndreessen HorowitzAntiAspire11+47 more
Lumeris uses AI combined with human-centered design to address the U.S. primary care shortage, co-creating an AI tool called Tom with physicians and patients to deliver Primary Care as a Service.
AI & Machine LearningDigital HealthHealthtechSt. Louis, US
W. Michael Long(Chairman & Chief Executive Officer, Lumeris Group Holdings Corporation)
Co-investorsBlue Venture FundsHavencrest Capital ManagementKleiner PerkinsBlueCross BlueShield Venture PartnersSandbox Industries
HealthtechBranford, US
Sofia Noori(Executive Officer, Director)Mariam Malik(Executive Officer)in
BoardLaura Veroneau(Director)Adrienne Rosenthal(Director)
Co-investors.406 VenturesOptum Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.